Edition:
India

Aerie Pharmaceuticals Inc (AERI.OQ)

AERI.OQ on NASDAQ Stock Exchange Global Market

70.45USD
22 Jun 2018
Change (% chg)

$3.10 (+4.60%)
Prev Close
$67.35
Open
$67.45
Day's High
$71.30
Day's Low
$65.70
Volume
448,383
Avg. Vol
116,988
52-wk High
$71.30
52-wk Low
$47.05

Select another date:

Wed, May 9 2018

BRIEF-Aerie Pharmaceuticals Reports Q1 Adjusted Loss Per Share $0.83

* AERIE PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

BRIEF-Aerie Pharmaceuticals Announces U.S. Launch Of Rhopressa 0.02%

* AERIE PHARMACEUTICALS ANNOUNCES U.S. LAUNCH OF RHOPRESSA® (NETARSUDIL OPHTHALMIC SOLUTION) 0.02%

BRIEF-Aerie Pharmaceuticals CEO Vicente Anido's 2017 Total Compensation Was $10.06 Million

* AERIE PHARMACEUTICALS INC SAYS CEO VICENTE ANIDO'S 2017 TOTAL COMPENSATION WAS $10.06 MILLION – SEC FILING Source text for Eikon: (http://bit.ly/2Kn2hS6) Further company coverage:

BRIEF-Aerie Pharmaceuticals Reports Q4 Adjusted Loss Per Share $1.38

* AERIE PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE AND 2018 GUIDANCE

BRIEF-Aerie Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock

* AERIE PHARMACEUTICALS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

BRIEF-Aerie Pharmaceuticals Commences Public Offering Of $75 Million Of Common Stock

* AERIE PHARMACEUTICALS ANNOUNCES PUBLIC OFFERING OF COMMON STOCK

BRIEF-Aerie Pharmaceuticals Appoints Julia Williams As Director Of Medical Affairs

* AERIE PHARMACEUTICALS ANNOUNCES APPOINTMENT OF JULIA WILLIAMS AS DIRECTOR OF MEDICAL AFFAIRS Source text for Eikon: Further company coverage:

Select another date: